Drugline is a fortnightly electronic drug bulletin for health professionals.
Scroll

Drugline

Drugline is a fortnightly electronic drug bulletin providing information on new medicines, new developments, current affairs, new indications, new PBS listings and deletions and general issues of importance to all health professionals. Click below to view the most recent volumes of Drugline.

Prescribing Restrictions for Hydroxychloroquine

Drugline Volume 391

The Therapeutic Goods Administration (TGA) has issued an alert advising of new prescribing restrictions for hydroxychloroquine. These restrictions have been introduced following reports of increased off-label prescribing for the management of coronavirus disease (COVID-19),…

Read more

Update on Influenza Vaccines

Drugline Volume 390

The Australian Technical Advisory Group on Immunisation (ATAGI) has released its advice for the administration of seasonal influenza vaccines in 2020. Influenza vaccines used in Australia this year will be quadrivalent and comprise two…

Read more

Generic Tiotropium Capsules

Drugline Volume 389

A generic tiotropium capsule has recently been added to the Pharmaceutical Benefits Scheme (PBS). Braltus® capsules are considered equivalent to Spiriva® capsules for the purposes of brand substitution on the PBS. However, some important…

Read more

Non-Steroidal Topical Therapy for Dermatitis

Drugline Volume 388

Topical corticosteroids have long been the mainstay of treatment for dermatitis that does not respond to moisturisers and emollients. Crisaborole is a new non-steroidal option approved for use in mild to moderate atopic dermatitis…

Read more

Updated PBS-listing for Pembrolizumab in treatment of metastatic non-small cell lung cancer

Drugline Volume 387

Pembrolizumab is now available on the Pharmaceutical Benefits Scheme (PBS) for the first-line treatment of metastatic non-small cell lung cancer (NSCLC) irrespective of programmed death ligand-1 (PD-L1) status. In the KEYNOTE-189 trial, pembrolizumab was used in…

Read more

Updated Oral and Dental Guidelines

Drugline Volume 386

An updated edition of the Therapeutic Guidelines: Oral and Dental has recently been released. This resource covers a broad range of conditions that are relevant to both dentists and medical practitioners. Some of the…

Read more
Load More

March 2020

December 2019

November 2019

October 2019

New Warning for Febuxostat (Oct. 18 2019)

Naloxone Nasal Spray (Oct. 04 2019)

April 2019

New High-Strength Insulin (Apr. 18 2019)

Tofacitinib Safety Issue (Apr. 05 2019)

March 2019

February 2019

January 2019

December 2018

October 2018

September 2018

August 2018

July 2018

April 2018

January 2018

December 2017

September 2017

Thunderstorm Asthma (Sep. 21 2017)

The Efficacy of Perampanel (Sep. 08 2017)

July 2017

June 2017

April 2017

March 2017

November 2016

September 2016

August 2016

April 2016

November 2015

Viekira Pak for Hepatitis C (Nov. 19 2015)

Micafungin (Nov. 05 2015)

October 2015

Dabigatran Antidote on the Horizon (Oct. 22 2015)

Akynzeo® (Oct. 08 2015)

September 2015

May 2015

April 2015

Victoza (liraglutide) (Apr. 23 2015)

Ultibro Breezhaler 100/50 (Apr. 09 2015)

March 2015

February 2015

December 2014

November 2014

October 2014

September 2014

World Pharmacist Day (Sep. 24 2014)

National Stroke Week (Sep. 11 2014)

August 2014

July 2014

Breo™ Ellipta® (Jul. 31 2014)

Use of Prolia® in Men (Jul. 17 2014)

Adcetris® (brentuximab vedotin) (Jul. 03 2014)

April 2014

March 2014

September 2013

August 2013

July 2013

June 2013

Riluzole for Motor Neurone Disease (Jun. 20 2013)

Mycamine (Jun. 06 2013)

May 2013

HPV Vaccine (May. 23 2013)

World Lupus Day (May. 09 2013)

December 2012

November 2012

August 2012